Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023

Upgrades

Craig-Hallum upgraded the previous rating for Carrols Restaurant Group Inc TAST from Hold to Buy. In the fourth quarter, Carrols Restaurant Group showed an EPS of $0.05, compared to $0.15 from the year-ago quarter. The current stock performance of Carrols Restaurant Group shows a 52-week-high of $2.69 and a 52-week-low of $1.28. Moreover, at the end of the last trading period, the closing price was at $2.15.

For Delta Air Lines Inc DAL, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Delta Air Lines had an EPS of $1.48, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $46.27 and a 52-week-low of $27.20. Delta Air Lines closed at $38.46 at the end of the last trading period.

According to Argus Research, the prior rating for DraftKings Inc DKNG was changed from Hold to Buy. DraftKings earned $0.53 in the fourth quarter, compared to $0.80 in the year-ago quarter. The stock has a 52-week-high of $22.11 and a 52-week-low of $9.77. At the end of the last trading period, DraftKings closed at $19.19.

For United Airlines Holdings Inc UAL, Exane BNP Paribas upgraded the previous rating of Underperform to Outperform. For the fourth quarter, United Airlines Holdings had an EPS of $2.46, compared to year-ago quarter EPS of $1.60. At the moment, the stock has a 52-week-high of $53.86 and a 52-week-low of $30.54. United Airlines Holdings closed at $52.44 at the end of the last trading period.

Northcoast Research upgraded the previous rating for Costco Wholesale Corp COST from Neutral to Buy. Costco Wholesale earned $3.30 in the second quarter, compared to $2.92 in the year-ago quarter. At the moment, the stock has a 52-week-high of $612.27 and a 52-week-low of $406.51. Costco Wholesale closed at $483.08 at the end of the last trading period.

Morgan Stanley upgraded the previous rating for ACM Research Inc ACMR from Underweight to Overweight. For the fourth quarter, ACM Research had an EPS of $0.19, compared to year-ago quarter EPS of $0.27. The current stock performance of ACM Research shows a 52-week-high of $82.83 and a 52-week-low of $5.46. Moreover, at the end of the last trading period, the closing price was at $11.85.

For Mercantile Bank Corp MBWM, Piper Sandler upgraded the previous rating of Neutral to Overweight. Mercantile Bank earned $1.37 in the fourth quarter, compared to $0.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.03 and a 52-week-low of $29.26. Mercantile Bank closed at $34.09 at the end of the last trading period.

For Esperion Therapeutics Inc ESPR, Credit Suisse upgraded the previous rating of Underperform to Neutral. Esperion Therapeutics earned $0.76 in the fourth quarter, compared to $1.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.87 and a 52-week-low of $3.81. Esperion Therapeutics closed at $5.08 at the end of the last trading period.

For NuStar Energy LP NS, Stifel upgraded the previous rating of Hold to Buy. NuStar Energy earned $0.34 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of NuStar Energy shows a 52-week-high of $17.75 and a 52-week-low of $12.80. Moreover, at the end of the last trading period, the closing price was at $16.12.

For Kimbell Royalty Partners LP KRP, Keybanc upgraded the previous rating of Sector Weight to Overweight. In the fourth quarter, Kimbell Royalty Partners showed an EPS of $0.48, compared to $0.44 from the year-ago quarter. The current stock performance of Kimbell Royalty Partners shows a 52-week-high of $20.08 and a 52-week-low of $14.48. Moreover, at the end of the last trading period, the closing price was at $16.30.

See all analyst ratings upgrades.

Downgrades

Barrington Research downgraded the previous rating for Anika Therapeutics Inc ANIK from Outperform to Market Perform. In the fourth quarter, Anika Therapeutics showed an EPS of $0.21, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.51 and a 52-week-low of $19.95. Anika Therapeutics closed at $28.87 at the end of the last trading period.

Stephens & Co. downgraded the previous rating for CareDx Inc CDNA from Overweight to Equal-Weight. CareDx earned $0.07 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of CareDx shows a 52-week-high of $41.50 and a 52-week-low of $8.10. Moreover, at the end of the last trading period, the closing price was at $10.65.

For SES AI Corp SES, RBC Capital downgraded the previous rating of Outperform to Sector Perform. The current stock performance of SES AI shows a 52-week-high of $10.18 and a 52-week-low of $2.87. Moreover, at the end of the last trading period, the closing price was at $3.00.

BMO Capital downgraded the previous rating for Qualtrics International Inc XM from Outperform to Market Perform. For the fourth quarter, Qualtrics International had an EPS of $0.03, compared to year-ago quarter EPS of $0.07. The current stock performance of Qualtrics International shows a 52-week-high of $30.95 and a 52-week-low of $9.32. Moreover, at the end of the last trading period, the closing price was at $17.26.

Northcoast Research downgraded the previous rating for Trimble Inc TRMB from Neutral to Sell. In the fourth quarter, Trimble showed an EPS of $0.60, compared to $0.62 from the year-ago quarter. The stock has a 52-week-high of $74.87 and a 52-week-low of $47.52. At the end of the last trading period, Trimble closed at $53.05.

According to Baird, the prior rating for Embark Technology Inc EMBK was changed from Outperform to Neutral. The current stock performance of Embark Technology shows a 52-week-high of $384.00 and a 52-week-low of $2.02. Moreover, at the end of the last trading period, the closing price was at $2.56.

For Joby Aviation Inc JOBY, Deutsche Bank downgraded the previous rating of Hold to Sell. In the fourth quarter, Joby Aviation showed an EPS of $0.11, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.15 and a 52-week-low of $3.15. Joby Aviation closed at $4.50 at the end of the last trading period.

MoffettNathanson downgraded the previous rating for Lightspeed Commerce Inc LSPD from Outperform to Market Perform. For the third quarter, Lightspeed Commerce had an EPS of $0.00, compared to year-ago quarter EPS of $0.07. The current stock performance of Lightspeed Commerce shows a 52-week-high of $34.14 and a 52-week-low of $12.71. Moreover, at the end of the last trading period, the closing price was at $15.37.

For Gossamer Bio Inc GOSS, Raymond James downgraded the previous rating of Outperform to Market Perform. In the third quarter, Gossamer Bio showed an EPS of $0.65, compared to $0.80 from the year-ago quarter. The current stock performance of Gossamer Bio shows a 52-week-high of $15.20 and a 52-week-low of $1.57. Moreover, at the end of the last trading period, the closing price was at $1.74.

HC Wainwright & Co. downgraded the previous rating for Aptinyx Inc APTX from Buy to Neutral. In the third quarter, Aptinyx showed an EPS of $0.23, compared to $0.31 from the year-ago quarter. The current stock performance of Aptinyx shows a 52-week-high of $3.17 and a 52-week-low of $0.17. Moreover, at the end of the last trading period, the closing price was at $0.19.

HC Wainwright & Co. downgraded the previous rating for TCR2 Therapeutics Inc TCRR from Buy to Neutral. TCR2 Therapeutics earned $0.79 in the third quarter, compared to $0.69 in the year-ago quarter. The stock has a 52-week-high of $3.88 and a 52-week-low of $0.82. At the end of the last trading period, TCR2 Therapeutics closed at $1.62.

For Ovintiv Inc OVV, BMO Capital downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Ovintiv showed an EPS of $0.91, compared to $1.25 from the year-ago quarter. The current stock performance of Ovintiv shows a 52-week-high of $63.30 and a 52-week-low of $37.27. Moreover, at the end of the last trading period, the closing price was at $44.01.

RBC Capital downgraded the previous rating for Office Properties Income Trust OPI from Sector Perform to Underperform. Office Props IT earned $1.13 in the fourth quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Office Props IT shows a 52-week-high of $26.22 and a 52-week-low of $12.17. Moreover, at the end of the last trading period, the closing price was at $16.89.

According to Jefferies, the prior rating for Radius Global Infrastructure Inc RADI was changed from Buy to Hold. Radius Global Infr earned $0.23 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.52 and a 52-week-low of $7.97. Radius Global Infr closed at $14.56 at the end of the last trading period.

Goldman Sachs downgraded the previous rating for Artisan Partners Asset Management Inc APAM from Neutral to Sell. For the fourth quarter, Artisan Partners Asset had an EPS of $0.65, compared to year-ago quarter EPS of $1.29. At the moment, the stock has a 52-week-high of $40.68 and a 52-week-low of $25.66. Artisan Partners Asset closed at $32.78 at the end of the last trading period.

According to William Blair, the prior rating for Qualtrics International Inc XM was changed from Outperform to Market Perform. In the fourth quarter, Qualtrics International showed an EPS of $0.03, compared to $0.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.95 and a 52-week-low of $9.32. Qualtrics International closed at $17.26 at the end of the last trading period.

According to Keybanc, the prior rating for Black Stone Minerals LP BSM was changed from Overweight to Sector Weight. In the fourth quarter, Black Stone Minerals showed an EPS of $0.82, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $20.24 and a 52-week-low of $11.43. At the end of the last trading period, Black Stone Minerals closed at $15.84.

See all analyst ratings downgrades.

Initiations

Wolfe Research initiated coverage on Enlight Renewable Energy Ltd ENLT with an Outperform rating. The price target for Enlight Renewable Energy is set to $21.00. The stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. At the end of the last trading period, Enlight Renewable Energy closed at $16.02.

With a Buy rating, Canaccord Genuity initiated coverage on Perrigo Co PLC PRGO. The price target seems to have been set at $49.00 for Perrigo. For the fourth quarter, Perrigo had an EPS of $0.75, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $43.90 and a 52-week-low of $30.78. At the end of the last trading period, Perrigo closed at $36.96.

With a Hold rating, Jefferies initiated coverage on Lexicon Pharmaceuticals Inc LXRX. The price target seems to have been set at $3.00 for Lexicon Pharmaceuticals. In the fourth quarter, Lexicon Pharmaceuticals showed an EPS of $0.16, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $3.48 and a 52-week-low of $1.31. Lexicon Pharmaceuticals closed at $2.60 at the end of the last trading period.

With a Buy rating, Ladenburg Thalmann initiated coverage on Adverum Biotechnologies Inc ADVM. The price target seems to have been set at $2.00 for Adverum Biotechnologies. For the third quarter, Adverum Biotechnologies had an EPS of $0.40, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $1.82 and a 52-week-low of $0.53. At the end of the last trading period, Adverum Biotechnologies closed at $0.77.

JP Morgan initiated coverage on Enlight Renewable Energy Ltd ENLT with an Overweight rating. The price target for Enlight Renewable Energy is set to $23.00. At the moment, the stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. Enlight Renewable Energy closed at $16.02 at the end of the last trading period.

WestPark Capital initiated coverage on Qualys Inc QLYS with a Buy rating. The price target for Qualys is set to $170.00. In the fourth quarter, Qualys showed an EPS of $1.01, compared to $0.84 from the year-ago quarter. The current stock performance of Qualys shows a 52-week-high of $162.36 and a 52-week-low of $101.10. Moreover, at the end of the last trading period, the closing price was at $121.30.

For Mineralys Therapeutics Inc MLYS, Evercore ISI Group initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.

Wells Fargo initiated coverage on Mineralys Therapeutics Inc MLYS with an Overweight rating. The price target for Mineralys Therapeutics is set to $27.00. The current stock performance of Mineralys Therapeutics shows a 52-week-high of $21.98 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $18.96.

With an Outperform rating, Credit Suisse initiated coverage on Enlight Renewable Energy Ltd ENLT. The price target seems to have been set at $22.00 for Enlight Renewable Energy. At the moment, the stock has a 52-week-high of $18.49 and a 52-week-low of $15.38. Enlight Renewable Energy closed at $16.02 at the end of the last trading period.

With an Outperform rating, Credit Suisse initiated coverage on Mineralys Therapeutics Inc MLYS. The price target seems to have been set at $40.00 for Mineralys Therapeutics. The current stock performance of Mineralys Therapeutics shows a 52-week-high of $21.98 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $18.96.

Compass Point initiated coverage on Upstart Holdings Inc UPST with a Sell rating. The price target for Upstart Hldgs is set to $6.00. For the fourth quarter, Upstart Hldgs had an EPS of $0.25, compared to year-ago quarter EPS of $0.89. At the moment, the stock has a 52-week-high of $151.67 and a 52-week-low of $12.01. Upstart Hldgs closed at $18.60 at the end of the last trading period.

Guggenheim initiated coverage on Mineralys Therapeutics Inc MLYS with a Buy rating. The price target for Mineralys Therapeutics is set to $32.00. The stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. At the end of the last trading period, Mineralys Therapeutics closed at $18.96.

With a Buy rating, B of A Securities initiated coverage on Mineralys Therapeutics Inc MLYS. The price target seems to have been set at $39.00 for Mineralys Therapeutics. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.

With a Buy rating, Roth MKM initiated coverage on Tenax Therapeutics Inc TENX. The price target seems to have been set at $6.00 for Tenax Therapeutics. For the third quarter, Tenax Therapeutics had an EPS of $2.20, compared to year-ago quarter EPS of $3.00. At the moment, the stock has a 52-week-high of $17.00 and a 52-week-low of $0.63. Tenax Therapeutics closed at $0.65 at the end of the last trading period.

EF Hutton initiated coverage on AERWINS Technologies Inc AWIN with a Buy rating. The price target for AERWINS Technologies is set to $2.00. At the moment, the stock has a 52-week-high of $7.25 and a 52-week-low of $0.99. AERWINS Technologies closed at $1.06 at the end of the last trading period.

Baird initiated coverage on CRISPR Therapeutics AG CRSP with a Neutral rating. The price target for CRISPR Therapeutics is set to $46.00. In the fourth quarter, CRISPR Therapeutics showed an EPS of $1.41, compared to $1.84 from the year-ago quarter. The stock has a 52-week-high of $86.95 and a 52-week-low of $38.94. At the end of the last trading period, CRISPR Therapeutics closed at $49.33.

With an Outperform rating, Baird initiated coverage on bluebird bio Inc BLUE. The price target seems to have been set at $10.00 for bluebird bio. In the third quarter, bluebird bio showed an EPS of $0.94, compared to $3.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.58 and a 52-week-low of $2.87. bluebird bio closed at $4.90 at the end of the last trading period.

Goldman Sachs initiated coverage on Arista Networks Inc ANET with a Buy rating. For the fourth quarter, Arista Networks had an EPS of $1.41, compared to year-ago quarter EPS of $0.82. The current stock performance of Arista Networks shows a 52-week-high of $145.17 and a 52-week-low of $89.11. Moreover, at the end of the last trading period, the closing price was at $142.58.

Goldman Sachs initiated coverage on Juniper Networks Inc JNPR with a Buy rating. Juniper Networks earned $0.65 in the fourth quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $38.14 and a 52-week-low of $25.18. At the end of the last trading period, Juniper Networks closed at $31.33.

Goldman Sachs initiated coverage on Cisco Systems Inc CSCO with a Neutral rating. Cisco Systems earned $0.88 in the second quarter, compared to $0.84 in the year-ago quarter. At the moment, the stock has a 52-week-high of $56.94 and a 52-week-low of $38.60. Cisco Systems closed at $49.42 at the end of the last trading period.

For F5 Inc FFIV, Goldman Sachs initiated coverage, by setting the current rating at Neutral. F5 earned $2.47 in the first quarter, compared to $2.89 in the year-ago quarter. The stock has a 52-week-high of $217.41 and a 52-week-low of $133.68. At the end of the last trading period, F5 closed at $145.17.

Stifel initiated coverage on Mineralys Therapeutics Inc MLYS with a Buy rating. The price target for Mineralys Therapeutics is set to $45.00. At the moment, the stock has a 52-week-high of $21.98 and a 52-week-low of $17.00. Mineralys Therapeutics closed at $18.96 at the end of the last trading period.

Piper Sandler initiated coverage on Allakos Inc ALLK with an Overweight rating. The price target for Allakos is set to $22.00. For the fourth quarter, Allakos had an EPS of $0.50, compared to year-ago quarter EPS of $1.73. At the moment, the stock has a 52-week-high of $8.73 and a 52-week-low of $2.54. Allakos closed at $5.40 at the end of the last trading period.

See all analyst ratings initiations.